Sesquiterpenoids from the Root of Panax Ginseng Attenuates Lipopolysaccharide-Induced Depressive-Like Behavior Through the Brain-Derived Neurotrophic Factor/Tropomyosin-Related Kinase B and Sirtuin Type 1/nuclear Factor-κB Signaling Pathways

Weidong Wang,Xiaofeng Liu,Jinping Liu,Enbo Cai,Yan Zhao,Haijun Li,Lianxue Zhang,Pingya Li,Yugang Gao
DOI: https://doi.org/10.1021/acs.jafc.7b04835
IF: 6.1
2017-01-01
Journal of Agricultural and Food Chemistry
Abstract:The previous study indicated sesquiterpenoids from the root of Panax ginseng (SPG) exhibited a significant antidepressant-like effect, which might be mediated by the modification of the dopaminergic, GABAergic, and glutamatergic systems. This study was to investigate antidepressant effects and mechanisms on the lipopolysaccharide (LPS)-induced depression-like behavior of SPG. In the tail suspension test (TST) and forced swimming test (FST), SPG (0.25 and 1 mg/kg, i.g.) and fluoxetine (20 mg/kg, i.p.) effectively reduced the immobility time. SPG treatment significantly reduced serum levels of IL-6 and TNF-α and increased suppressed superoxide dismutase (SOD) activity in the hippocampus. In addition, SPG effectively upregulated the brain-derived neurotrophic factor (BDNF), tropomyosin-related kinase B (TrkB), and sirtuin type 1 (Sirt 1) expression in the hippocampus and downregulated the inhibitor of κB-α (IκB-α) and nuclear factor-κB (NF-κB) phosphorylation. These results suggested that SPG exhibited an antidepressant-like effect through the BDNF/TrkB and Sirt 1/NF-κB signaling pathways.
What problem does this paper attempt to address?